Month: September 2024

COFACE SA: Disclosure of total number of voting rights and number of shares in the capital as at 31 August 2024 Paris, 05 September 2024 – 17.45Total Number of Shares Capital Theoretical Number of Voting Rights1 Number of Real Voting Rights2150,179,792 150,179,792 149,384,361(1)   including own shares(2)   excluding own shares Regulated documents posted by COFACE SA have been secured and authenticated with the blockchain technology by Wiztrust. You can check the authenticity on the website www.wiztrust.com.  About Coface   COFACE SA is a société anonyme (joint-stock corporation), with a Board of Directors (Conseil d’Administration) incorporated under the laws of France, and is governed by the provisions of the French Commercial Code. The Company is registered with the Nanterre Trade and Companies...

Disclosure Of Trading In Own SharesFor August 2024 CLICHY – 05 SEP 2024 In compliance with general regulation on share buy-backs, SOCIÉTÉ BIC declares below the transactions made on its own shares for August 2024:Date Number of shares Average weighted price in € Amount in €05/08/2024 2,459 56.4552 138,823.3406/08/2024 2,741 57.3061 157,076.0207/08/2024 6,000 57.7000 346,200.0008/08/2024 921 57.9151 53,339.8109/08/2024 14,443 58.3000 842,026.9009/08/2024 5,223 57.9850 302,855.6612/08/2024 36,083 58.0000 2,092,814.0012/08/2024 5,500 56.8000 312,400.0028/08/2024 4,752 60.3804 286,927.6629/08/2024 754 60.4755 45,598.5330/08/2024 1,955 60.9918 119,238.97TOTAL 80,831 58.1126 4,697,300.88ABOUT BIC A...

Strasbourg, France, September 5, 2024, 5 : 45 PM CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces that its management will participate in the following upcoming investor meetings taking place in Paris, France:6th HealthTech Innovation Days (HTID), September 17 & 18, 2024 Investor Access Forum, October 15 & 16, 2024*** About Transgene Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer. Transgene’s programs utilize viral vector technology with the goal of indirectly or directly killing cancer cells. The Company’s clinical-stage programs consist of a portfolio of therapeutic vaccines and oncolytic viruses: TG4050, the first individualized...

TORONTO, Sept. 05, 2024 (GLOBE NEWSWIRE) — Montero Mining and Exploration Ltd. (TSX-V: MON) is pleased to announce the appointment of Timothy (Tim) Livesey as a Non-Executive Director to Montero’s Board of Directors, effective as of September 5, 2024. Tim Livesey is a seasoned geologist and mining professional with over 30 years of experience in gold and base metal exploration, working on a number of exploration and advanced stage projects through feasibility to development. He also brings expertise in international investment disputes and arbitration. Tim’s career spans 14 years at Barrick Gold, where he held various global roles. He was instrumental in the development of the Tethyan Copper Company Joint Venture at Reko Diq copper-gold project in Pakistan, a project that later became involved in an ICSID arbitration process. Tim...

Sanoma Corporation, Stock Exchange Release, 5 September 2024 at 17:55 EET Sanoma issues a EUR 150 million social bond NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE OR SUCH OTHER COUNTRIES OR OTHERWISE IN SUCH CIRCUMSTANCES IN WHICH THE OFFERING OF THE NOTES OR THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Sanoma Corporation (“Sanoma”) issues senior unsecured social notes of EUR 150 million (the “Notes”). The maturity of the Notes is three years and they mature on 13 September 2027. The Notes carry fixed annual interest of 4.000 percent. The issue price of the notes is 99.872 percent. The offering was allocated to over 40 investors. “Sanoma Learning’s products and services enable and support teachers and...

PRINCETON, N.J., Sept. 05, 2024 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of nimodipine that addresses high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage (aSAH), today announced that the Company will participate in the H.C. Wainwright 26th Annual Global Investment Conference, to be held September 9th – 11th in New York, NY. Prashant Kohli, Chief Executive Officer of Acasti, will be available for one-on-meetings on September 9th and 10th. H.C. Wainwright 26th Annual Global Investment Conference Title: Acasti Corporate Presentation Presentation Availability: September 9th at 7:00AM EDT (On-Demand) Webcast Link: Click here One-on-One Availability: September 9-10, 2024 About the Acasti...

Valoe Corporation         Stock Exchange Release         5 September 2024 at 17.25 Finnish time          Senior Vice President for Valoe Corporation’s (the “Company”) solar cell business in Lithuania, Mr. Jose Basso, has filed for the Company’s bankruptcy. The application relates to claims arising from an agreement between the Company and Mr. Basso, with the claim amount being approximately EUR 60,000. The claims are disputed and Valoe intends to oppose the application. The agreement between the parties has been terminated on 31 May 2024. In Mikkeli 5 September 2024 Valoe Corporation Board of Directors For more information:Iikka Savisalo, President and CEO, Valoe Corporation Tel. +358 40 521 6082email: iikka.savisalo@valoe.com Distribution:NASDAQ OMX, Helsinki Main media www.valoe.com Valoe Corporation designs, manufacturers,...

JACKSONVILLE, Fla., Sept. 05, 2024 (GLOBE NEWSWIRE) — CSX Corp. (NASDAQ: CSX) President and Chief Executive Officer, Joe Hinrichs, will address the 12th Annual Morgan Stanley Laguna Conference in California on Thursday, September 12, at 9:20 a.m. Pacific time. This address will be broadcast live via webcast at http://investors.csx.com. A replay will be available following the conclusion of this event. This announcement, as well as additional financial information, is available on the company’s website at http://investors.csx.com. About CSX CSX, based in Jacksonville, Florida, is a premier transportation company. It provides rail, intermodal and rail-to-truck transload services and solutions to customers across a broad array of markets, including energy, industrial, construction, agricultural and consumer products. For nearly 200...

Company announcement no. 32 / 2024 Schindellegi, Switzerland – 5 September 2024Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them Pursuant to the Market Abuse Regulation Article 19, Trifork Group AG (Swiss company registration number CHE-474.101.854) (“Trifork”) hereby notifies receipt of information of the following transactions made by a person or entity closely associated with a person discharging managerial responsibilities in Trifork.1. Details of the person discharging managerial responsibilities/person closely associateda) Name Jørn Larsen2. Reason for the notificationa) Position/status CEOb) Initial notification/ Amendment Initial notification3. Details of the issuer, emission allowance market participant, auction platform, auctioneer...